These authors found no difference between treatment with radiotherapy or chemoradiotherapy in the low risk (none of above factors present) and intermediate risk (1 factor present) categories, although there was a clear trend in favor of treatment with radiotherapy combined with a non-MDR–based chemotherapy regime.
← all excerpts
Extranodal Natural Killer/T-cell Lymphoma, Nasal Type: Diagnosis and Treatment.
1
—
—